Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price

(AJANTPHARM)

Mid Cap

Healthcare Sector

Check the latest share price of Ajanta Pharma Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹2765.8

▲0.34%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Ajanta Pharma Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹2,740
    Day's Price Range
    ₹2,801.4

  • 52 Week's Low

    52 Week's High

    ₹2,111.05
    52-Week Price Range
    ₹3,485
1 Month Return-0.44 %
3 Month Return-10.95 %
1 Year Return+ 21.14 %
Previous Close₹2,775.20
Open₹2,791.50
Volume78.71K
Upper Circuit-
Lower Circuit-
Market Cap₹32,044.95Cr

Ajanta Pharma Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹32,044.95 Cr

Return on Equity (ROE)

23.78

Return on capital employed (ROCE)

29.6

P/B Ratio

4.9

Dividend Yield

0.53

EPS (TTM)

55.3403689357929

Sector

Pharmaceuticals

How to invest in Ajanta Pharma Ltd

Investing in Ajanta Pharma Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Ajanta Pharma Ltd or AJANTPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Ajanta Pharma Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Ajanta Pharma Ltd with just a few clicks!

Ajanta Pharma Ltd Valuation

Track how the P/E of Ajanta Pharma Ltd has moved over time to understand valuation trends.

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (36.43x)

December 15, 2023

Industry (58.33x)

December 15, 2023

Highest (37.94x)

November 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 36.43x

Analysts Recommendation on Ajanta Pharma Ltd

Get updated buy, sell, and hold recommendations by analysts on Ajanta Pharma Ltd.

based on 12 analysts

BUY

83.33%

Buy

8.33%

Hold

8.33%

Sell

83.33% of analysts recommend a 'BUY' rating for Ajanta Pharma Ltd. Average target of ₹1812.67

Source: S&P Global Market Intelligence

Analysts Forecast on Ajanta Pharma Ltd

Get share price movements and forecasts by analysts on Ajanta Pharma Ltd.

Ajanta Pharma Ltd price forecast by 12 analysts

Downside of-29.34%

High

₹2070

Target

₹1812.67

Low

₹1532

Ajanta Pharma Ltd target price ₹1812.67, a slight downside of -29.34% compared to current price of ₹2765.8. According to 12 analysts rating.

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Financials

Get the annual and quarterly financial summary of Ajanta Pharma Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹1,021.04Cr (-)₹1,028.44Cr (↑0.72%)₹1,105.15Cr (↑7.46%)₹1,054.08Cr (↓4.62%)₹1,144.92Cr (↑8.62%)
Net Income₹208.12Cr (-)₹195.30Cr (↓6.16%)₹210.03Cr (↑7.54%)₹202.72Cr (↓3.48%)₹245.77Cr (↑21.24%)
Net Profit Margin20.38% (-)18.99% (↓6.82%)19.00% (↑0.05%)19.23% (↑1.21%)21.47% (↑11.65%)
Value in ₹ crore
Details2019202020212022
Total Assets₹2,521.51Cr (-)₹3,049.15Cr (↑20.93%)₹3,532.06Cr (↑15.84%)₹3,780.49Cr (↑7.03%)
Total Liabilities₹379.43Cr (-)₹587.85Cr (↑54.93%)₹647.08Cr (↑10.08%)₹611.31Cr (↓5.53%)
Value in ₹ crore
Details20182019202020212022
Operating Cash Flow₹219.17Cr (-)₹311.82Cr (↑42.27%)₹300.88Cr (↓3.51%)₹466.99Cr (↑55.21%)₹542.34Cr (↑16.14%)

Ajanta Pharma Ltd Index Inclusions

BSE 500

₹34,765.79

0 (▲0%)

NIFTY PHARMA

₹21,676.65

-1.06 (▲-231.45%)

S&P BSE 150 MidCap

₹14,959.91

0 (▲0%)

Nifty 500

₹0.00

0 (▲0%)

BSE Mid-Cap

₹43,097.01

0 (▲0%)

BSE Healthcare

₹42,555.65

0 (▲0%)

Nifty LargeMidcap 250

₹15,416.05

0.1 (▲15.35%)

S&P BSE 250 LargeMidCap

₹10,383.27

0 (▲0%)

S&P BSE 400 MidSmallCap

₹11,171.57

0 (▲0%)

Nifty Midcap 150

₹20,009.05

0.21 (▲42.35%)

Nifty MidSmallcap 400

₹18,431.30

0.21 (▲38.8%)

S&P BSE AllCap

₹10,471.31

0 (▲0%)

Ajanta Pharma Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ajanta Pharma Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
66.21%
0.16
Foreign Institutions
10.03%
0.23
Mutual Funds
13.72%
-0.37
Retail Investors
7.74%
-2.18
Others
2.31%
4.17

Ajanta Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma Ltd with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Ajanta Pharma Ltd
Ajanta Pharma Ltd
BUY₹32,044.95 Cr34.61%0.51NANA
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
BUY₹63,424.92 Cr22.06%0.55NANA
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
BUY₹87,426.64 Cr31.24%0.59NANA
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd
HOLD₹46,605.29 Cr17.26%0.55NANA
Syngene International Ltd
Syngene International Ltd
BUY₹28,250.05 Cr30.32%0.64NANA
See all

Ajanta Pharma Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Ajanta Pharma Ltd.

  • Ajanta Pharma to Release Q4 FY 2025 Results - 22 Apr, 2025

    Ajanta Pharma Limited will announce its audited financial results for Q4 FY 2025 on April 30, 2025, followed by an earnings conference call for stakeholders.

  • Jefferies Initiates Buy on Ajanta Pharma Stock - 15 Apr, 2025

    Jefferies has initiated coverage on Ajanta Pharma with a Buy rating and a target price of ₹2,850, citing strong growth potential in branded generics markets. The firm forecasts a 19% PAT CAGR from FY25 to FY27, highlighting Ajanta's competitive advantages and consistent revenue growth.

  • Ajanta Pharma Projected for 12% Upside by Axis Capital - 24 Mar, 2025

    Axis Capital initiated coverage on Ajanta Pharma with a target price of Rs 3,050, projecting a 12% upside. The brokerage highlights a robust growth outlook, driven by new launches and strong product portfolio, expecting a 12% CAGR for the India business from FY 2024 to FY 2028.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.89% to 15.13% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AJANTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AJANTPHARM stock has moved up by 3.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 216.48 Cr → 232.88 Cr (in ₹), with an average increase of 7.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 25.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.26% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.20K Cr → 1.17K Cr (in ₹), with an average decrease of 2.5% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 9.26% to 8.86% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.45% to 7.39% in Mar 2025 quarter

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Revenue: ₹1,144.92Cr as on June 2024 (Q2 24)
Net Profit: ₹245.77Cr as on June 2024 (Q2 24)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Indian Mutual Funds that own Ajanta Pharma Ltd

Check out the Mutual Funds with significant holdings in Ajanta Pharma Ltd.

Futures and Options

View the latest movement in Ajanta Pharma Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Ajanta Pharma Ltd price today?

Ajanta Pharma Ltd share price today stands at ₹2765.8, Open: ₹2791.5, Previous Close: ₹2775.2, High: ₹2801.4, Low: ₹2740, 52 Week High: ₹3485, 52 Week Low: ₹2111.05.

How to Buy Ajanta Pharma Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Ajanta Pharma Ltd shares

What are today's traded volumes of Ajanta Pharma Ltd?

Today's traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 78.71K.

What is today's market capitalisation of Ajanta Pharma Ltd?

Today's market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹32,044.95 Cr.

What is the 52 Week High and Low Range of Ajanta Pharma Ltd?

Ajanta Pharma Ltd (AJANTPHARM)
Price
52 Week High
₹3485
52 Week Low
₹2111.05

How much percentage Ajanta Pharma Ltd is down from its 52 Week High?

Ajanta Pharma Ltd (AJANTPHARM) share price is ₹2765.8. It is down -20.64% from its 52 Week High price of ₹3485

How much percentage Ajanta Pharma Ltd is up from its 52 Week low?

Ajanta Pharma Ltd (AJANTPHARM) share price is ₹2765.8. It is up 31.02% from its 52 Week Low price of ₹2111.05